2022
DOI: 10.1002/pd.6092
|View full text |Cite
|
Sign up to set email alerts
|

A microfluidic platform for high‐purity cell free DNA extraction from plasma for non‐invasive prenatal testing

Abstract: Objectives Increase the yield and purity of cell‐free DNA (cfDNA) extracted from plasma for non‐invasive prenatal testing (NIPT) as inefficiencies in this extraction and purification can dramatically affect the sensitivity and specificity of the test. Methods This work integrates cfDNA extraction from plasma with a microfluidic chip platform by combining magnetic bead‐based extraction and electroosmotic flow on the microfluidic chip. Various wash buffers and voltage conditions were simulated using COMSOL Multi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
4
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 51 publications
(104 reference statements)
0
4
0
Order By: Relevance
“…Furthermore, investigations of chemical syntheses in various microreactors configurations may also represent an important base for designing chips for other purposes. Specifically, fluid dynamics analyses may be of good use for researchers aiming to fabricate microfluidic platforms for emerging biomedical applications, including non-invasive diagnosis devices [ 108 , 109 , 110 , 111 , 112 ], cell culture media (organs-on-a-chip) [ 113 , 114 , 115 , 116 , 117 ], and precise drug-delivery systems [ 118 , 119 , 120 , 121 ].…”
Section: Conclusion and Future Perspectivesmentioning
confidence: 99%
“…Furthermore, investigations of chemical syntheses in various microreactors configurations may also represent an important base for designing chips for other purposes. Specifically, fluid dynamics analyses may be of good use for researchers aiming to fabricate microfluidic platforms for emerging biomedical applications, including non-invasive diagnosis devices [ 108 , 109 , 110 , 111 , 112 ], cell culture media (organs-on-a-chip) [ 113 , 114 , 115 , 116 , 117 ], and precise drug-delivery systems [ 118 , 119 , 120 , 121 ].…”
Section: Conclusion and Future Perspectivesmentioning
confidence: 99%
“…NGS is a markedly valuable tool for diagnostics and discovery because it generates millions of reads and is exceedingly sensitive to nucleic acid mutations [9][10][11][12] . Unfortunately, while innovations in sequencing technology have reduced requisite cost, time, and workload, sample (library) preparation has largely remained rudimentary and labor-intensive [13][14][15][16] . Even for applications requiring less data, such as microbial whole genome sequencing (WGS) or RNA-seq, the majority of the total sequencing cost can be attributed to library preparation,…”
mentioning
confidence: 99%
“…Consequently, expensive robotic liquid handlers dominate research and clinical applications in core laboratories, and small laboratories suffer from the bottleneck of labor-intensive manual protocols. Automation innovation for small laboratories is necessary to accelerate NGS-based research, eliminate sources of human error, and reduce hands-on time [13][14][15][16] . Our previous work started with the innovative concept of integrating liquid mixing steps with thermodynamically driven steps such as ligation and amplification via a single capillary tube heating system [13][14][15][16] .…”
mentioning
confidence: 99%
See 1 more Smart Citation